L-ARGININE CRYSTALLINE SALT OF (R)-2-(7-(4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOL-3-YL)ACETIC ACID (COMPOSITE 1) FOR USE IN S1P1 RECEPTOR-ASSOCIATED DISORDERS
MA42807AUndetermined Publication Date: 2018-07-25ARENA PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA42807
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2015-08-20
- Filing Date
- 2016-06-21
- Publication Date
- 2018-07-25
Need to check novelty before this filing date? Find Prior Art
No text content released.